Search the Newsreel

Alumis (NASDAQ:ALMS) Shares Gap Down After Earnings Miss

Alumis Inc. (NASDAQ:ALMS) experienced a significant share price drop after reporting disappointing earnings, missing both revenue and EPS consensus estimates. Despite the poor financial results and insider selling, analyst sentiment remains largely positive with a "Moderate Buy" consensus rating and a target price of …

Alumis (NASDAQ:ALMS) Issues Earnings Results

Alumis (NASDAQ:ALMS) reported earnings that missed analyst expectations, with an adjusted loss of $1.11 per share against a $0.73 consensus estimate and revenue of $1.66 million versus a $3.47 million forecast. Following the announcement, ALMS shares declined by $1.14 to $24.41. Despite some analyst …

Alumis Inc. (ALMS) reports $235M loss but ends quarter with $502M cash

Earnings Flash (ALMS) Alumis Inc. Reports Q2 Revenue $1.7M, Vs. FactSet Est of $3.5M

Alumis Inc. (ALMS) reported its second-quarter revenue, which came in at $1.7 million. This figure was significantly lower than FactSet's estimated revenue of $3.5 million, indicating a miss on analyst expectations for the quarter.

Alumis Reports Second Quarter 2026 Financial Results and Highlights Recent Achievements

Alumis Inc. reported its second-quarter 2026 financial results, highlighting strong long-term data for envudeucitinib in plaque psoriasis, with 54% of patients achieving complete skin clearance. The company plans to submit a New Drug Application for envudeucitinib in moderate-to-severe plaque psoriasis in Q4 2026 and …

California State Teachers Retirement System Raises Stock Position in Alumis Inc. $ALMS

The California State Teachers Retirement System significantly increased its stake in Alumis Inc. (NASDAQ:ALMS) by 2,222.5% in the first quarter, now holding 80,845 shares valued at $1.78 million. This move is part of a broader trend of institutional investors initiating or expanding positions in …

Gaming Realms Increases Treasury Stock With Latest Share Buyback

Gaming Realms Expands Treasury Stock Through Latest Share Buyback

Alumis (NASDAQ:ALMS) Trading Down 9.6% - Should You Sell?

Alumis Inc. (NASDAQ:ALMS) shares dropped 9.6% to $24.89 during mid-day trading on Tuesday, with significantly reduced trading volume. This comes after the clinical-stage biopharmaceutical company missed quarterly earnings expectations and saw insiders sell shares, despite generally positive analyst ratings and new institutional investments from …

Alumis Psoriasis Treatment Shows Leading Skin Clearance Rates

Alumis's investigational oral therapy, envudeucitinib, has demonstrated leading skin clearance rates for patients with moderate-to-severe plaque psoriasis, achieving high PASI 90 and PASI 100 response rates in its ONWARD3 long-term extension study. The treatment maintained a favorable tolerability profile and the company plans to …

Gaming Realms plc (GMR) Repurchases 152,892 Shares at Up to 31.90p Amid Ongoing Buyback Scheme

Alumis reports 54% complete skin clearance in psoriasis trial

Alumis Inc. announced positive topline results from its ONWARD3 long-term extension study for moderate-to-severe plaque psoriasis, revealing that 54% of patients achieved complete skin clearance (PASI 100) after 48 weeks of continuous envudeucitinib treatment. The investigational oral TYK2 inhibitor demonstrated a consistent safety profile, …

Alumis: Envudeucitinib Shows 54% PASI 100 at 48 Weeks, NDA on Track for 4Q 2026

Alumis announced that its drug envudeucitinib achieved 54% PASI 100 (complete skin clearance) at 48 weeks in the ONWARD3 study for psoriasis. The company also reported strong durability and consistent safety data across its integrated program. Alumis plans to submit a New Drug Application …

First Trust Advisors LP Takes $1.46 Million Position in Alumis Inc. $ALMS

First Trust Advisors LP has acquired a new position in Alumis Inc. (NASDAQ:ALMS) worth approximately $1.46 million, purchasing 66,099 shares. This comes as other institutional investors have also adjusted their holdings in the biopharmaceutical company. Despite ongoing quarterly losses and a full-year loss forecast, …

We Ran A Stock Scan For Earnings Growth And FIH Mobile (HKG:2038) Passed With Ease

Alumis Inc. $ALMS Shares Bought by The Manufacturers Life Insurance Company

The Manufacturers Life Insurance Company significantly increased its stake in Alumis Inc. (NASDAQ:ALMS) by 775.6% in the first quarter, holding 154,634 shares valued at $3.4 million. Other major investors like Samsara Biocapital, Vanguard, Cormorant Asset Management, and Octagon Capital also expanded their positions. Despite …

Negri Sembilan Oil Palms Berhad Reports Production Results for the Month of July 2026

Technical Reactions to ALMS Trends in Macro Strategies

This article analyzes Alumis Inc. (NASDAQ: ALMS) using AI models to provide technical reactions to macro trends. It highlights weak near and mid-term sentiment but a strong long-term outlook, identifying an exceptional risk-reward short setup. The report also details institutional trading strategies, including position …

FMR reports 5.5% stake in Alumis Inc | ALMS SEC Filing - Form SCHEDULE 13G

FMR LLC has filed a Schedule 13G reporting a 5.5% beneficial ownership stake in Alumis Inc. (ALMS), totaling 6,769,170.01 shares. The filing indicates FMR LLC holds sole voting power over 6,767,075.00 shares and sole dispositive power over 6,769,170.01 shares. Abigail P. Johnson is also …

Alumis Inc. (ALMS) CDO sells 2,572 shares to cover RSU taxes

Alumis Inc.'s Chief Development Officer, Bradley Mark Christopher, sold 2,572 shares of common stock on August 3, 2026, at a weighted average price of $26.37 per share. This non-discretionary "sell-to-cover" transaction was to satisfy tax obligations arising from restricted stock unit vesting. After the …

Alumis Inc. (ALMS) officer sells 2,692 shares in tax sell-to-cover trade

Alumis Inc.'s Chief Business & Strategy Officer, Roy C. Hardiman, sold 2,692 shares of common stock on August 3, 2026, at a weighted average price of $26.37 per share. This sale was a non-discretionary "sell-to-cover" transaction to satisfy tax obligations from vested restricted stock …

Alumis (ALMS) to Post Quarterly Earnings on Wednesday

Gaming Realms Expands Treasury Stock with Latest Share Buyback

Janus Henderson Group PLC Takes $46.79 Million Position in Alumis Inc. $ALMS

ALMS|Alumis Inc|Price:26.970|Chg%:-1.280

This article provides a comprehensive stock analysis of Alumis Inc (ALMS), highlighting its relatively healthy fundamentals, significant growth potential, and "Strong Buy" analyst rating with a high price target. It details the company's biopharmaceutical focus, including its pipeline of therapies for immune-mediated and neuroinflammatory …

Stempoint Capital LP Buys New Stake in Alumis Inc. $ALMS

166,959 Shares in Alumis Inc. $ALMS Purchased by Ally Bridge Group NY LLC

Alumis Inc. (NASDAQ:ALMS) Receives Average Recommendation of "Moderate Buy" from Brokerages

Gaming Realms Adds to Treasury Stock in Ongoing Share Buyback

Alumis Inc (ALMS) Institutional Confidence

Alumis Inc (ALMS) has an institutional shareholding score of 7.00, placing it 80th out of 385 in the Biotechnology & Medical Research industry. The institutional shareholding proportion is 82.61%, marking a 0.78% quarter-over-quarter increase. Chuck Royce is the largest institutional shareholder, holding 491.80K shares, …

venBio Partners LLC Decreases Stock Position in Alumis Inc. $ALMS

Gaming Realms Delivers Higher Earnings and Global Expansion Despite UK Tax Changes

Can Gaming Realms (LSE:GMR) Keep Expanding Despite Industry Changes?